Pillstats
Rx only · Tablet · Oral

Metoclopramide

Metoclopramide Hydrochloride

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US38 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA03FA01
RxCUI (US)6915
US makers19 labelers
Packages70
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.014$0.027$0.041$0.054Dec 2025Apr 2026Jul 2026
$0.041
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
18
Active US suppliers
32%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

91K182K273K365K2025 Q12025 Q22025 Q32025 Q42026 Q1
295K
Rx · 2026 Q1
16.0M
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager12SUPPLYING
NuCare Pharmaceuticals, Inc.unknown10SUPPLYING
Proficient Rx LPunknown8SUPPLYING
Ipca Laboratories Limitedunknown8SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown5SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown5SUPPLYING
REMEDYREPACK INC.repackager3SUPPLYING
Safecor Health, LLCunknown2SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown2SUPPLYING
Northwind Health Company, LLCunknown2SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Coupler LLCunknown2SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING
AvKAREunknown1SUPPLYING

+ 4 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 23, 2025
    RECALLRecall (Class II): Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb,…

    Presence of foreign tablets/capsules. — Recalling firm: Teva Pharmaceuticals USA, Inc — USA Nationwide